Pharmaceutical discount agreements
Original notice title
Germany – Pharmaceutical products – Arzneimittelrabattverträge gem. § 130a Abs. 8 SGB V im Rahmen von Open-House-Verfahren
Opportunity Score
Why this score?
Opportunity
50 / 100
Complexity
40 / 100
Risk factors
No estimated contract value or volume provided; cannot assess potential revenue
Procedure described as open-house but uses standard tender form; legal implications unclear
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Moderate opportunityKey Facts
- Supplies contract
- 3 lots
- Duration until Feb 2028
- Non-exclusive discount agreements for 32 pharmaceutical active substances (various therapeutic areas)
- Contracts run from 01.03.2026 to 29.02.2028, with possible extension up to 12 months per lot
Show full summary
IKK classic is conducting an open-house procedure for non-exclusive discount agreements on pharmaceutical products (32 lots for different active substances) from 01.03.2026 to 29.02.2028. The procedure allows continuous joining until 05.01.2028. No estimated value or award criteria are provided; conditions are fixed and non-negotiable. Eligibility is limited to pharmaceutical entrepreneurs. Submission is by email or post (electronic not allowed).
Risks
No estimated contract value or volume provided; cannot assess potential revenue
Procedure described as open-house but uses standard tender form; legal implications unclear
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Tenderer must be a pharmaceutical entrepreneur (pharmazeutischer Unternehmer) per §4 Abs. 18 AMG
Administrative
- Submission of signed contract, self-declarations, and commercial register extract (not older than 6 months)
- No electronic submission; documents must be sent by email or post
Requirements may be incomplete.
Buyer
Lots (32)
LOT-0001
Abobotulinumtoxin
Abobotulinumtoxin (M03AX21/M03AX01)
Location
Duration
Category
Award details
Abobotulinumtoxin
ATC-Code: M03AX21 (ADV)
M03AX01 (WHO)
Value note
Show original TED data
Original lot title
Abobotulinumtoxin; ATC-Code: M03AX21 (ADV); M03AX01 (WHO)
Original TED description
Abobotulinumtoxin; ATC-Code: M03AX21 (ADV); M03AX01 (WHO)
LOT-0002
Atropin
Atropin (S01FA01)
Location
Duration
Category
Award details
Atropin
ATC-Code: S01FA01
Value note
Show original TED data
Original lot title
Atropin; ATC-Code: S01FA01
Original TED description
Atropin; ATC-Code: S01FA01
LOT-0003
Azelainsaeure
Azelainsaeure (D10AX03)
Location
Duration
Category
Award details
Azelainsäure
ATC-Code: D10AX03
Value note
Show original TED data
Original lot title
Azelainsäure; ATC-Code: D10AX03
Original TED description
Azelainsäure; ATC-Code: D10AX03
LOT-0004
Bexaroten; ATC-Code: L01XF03
Bexaroten; ATC-Code: L01XF03
Location
Duration
Category
Award details
Bexaroten
ATC-Code: L01XF03
LOT-0005
Buserelin; ATC-Code:L02AE01
Buserelin; ATC-Code:L02AE01
Location
Duration
Category
Award details
Buserelin
ATC-Code:L02AE01
LOT-0006
Choriongonadotropin alfa; ATC-Code: G03GA08
Choriongonadotropin alfa; ATC-Code: G03GA08
Location
Duration
Category
Award details
Choriongonadotropin alfa
ATC-Code: G03GA08
LOT-0007
Clindamycin; ATC-Code: G01AA10
Clindamycin; ATC-Code: G01AA10
Location
Duration
Category
Award details
Clindamycin
ATC-Code: G01AA10
LOT-0008
Cyanocobalamin; Injektionslösung; ATC-Code: B03BA01
Cyanocobalamin; Injektionslösung; ATC-Code: B03BA01
Location
Duration
Category
Award details
Cyanocobalamin
Injektionslösung
ATC-Code: B03BA01
LOT-0009
Duloxetin; Wirkstärke 45 mg, 90 mg und 120 mg; Packungsgröße: 98 HKM (N3); ATC-Code: N06AX21
Duloxetin; Wirkstärke 45 mg, 90 mg und 120 mg; Packungsgröße: 98 HKM (N3); ATC-Code: N06AX21
Location
Duration
Category
Award details
Duloxetin
Wirkstärke 45 mg, 90 mg und 120 mg
Packungsgröße: 98 HKM (N3)
ATC-Code: N06AX21
LOT-0010
Estradiol 0,5-Wasser; Gel; Wirkstärke 0,62 mg; ATC-Code: G03CA03
Estradiol 0,5-Wasser; Gel; Wirkstärke 0,62 mg; ATC-Code: G03CA03
Location
Duration
Category
Award details
Estradiol 0,5-Wasser
Gel
Wirkstärke 0,62 mg
ATC-Code: G03CA03
LOT-0011
Estradiol 0,5-Wasser; Transdermales Spray; ATC-Code: G03CA03
Estradiol 0,5-Wasser; Transdermales Spray; ATC-Code: G03CA03
Location
Duration
Category
Award details
Estradiol 0,5-Wasser
Transdermales Spray
ATC-Code: G03CA03
LOT-0012
Everolimus; bei Renalem Angiomyolipom assoziiert mit tuberöser Sklerose oder bei Subependymalem Riesenzellastrozytom im Zusammenhang mit tuberöser Sklerose; ATC-Code: L01EG02
Everolimus; bei Renalem Angiomyolipom assoziiert mit tuberöser Sklerose oder bei Subependymalem Riesenzellastrozytom im Zusammenhang mit tuberöser Sklerose; ATC-Code: L01EG02
Location
Duration
Category
Award details
Everolimus
bei Renalem Angiomyolipom assoziiert mit tuberöser Sklerose oder bei Subependymalem Riesenzellastrozytom im Zusammenhang mit tuberöser Sklerose
ATC-Code: L01EG02
LOT-0013
Follitropin delta; ATC-Code: G03GA10
Follitropin delta; ATC-Code: G03GA10
Location
Duration
Category
Award details
Follitropin delta
ATC-Code: G03GA10
LOT-0014
Goserelin; ATC-Code: L02AE03
Goserelin; ATC-Code: L02AE03
Location
Duration
Category
Award details
Goserelin
ATC-Code: L02AE03
LOT-0015
Lösungen zur parenteralen Ernährung - Kombinationen; ATC-Code: B05BA10
Lösungen zur parenteralen Ernährung - Kombinationen; ATC-Code: B05BA10
Location
Duration
Category
Award details
Lösungen zur parenteralen Ernährung - Kombinationen
ATC-Code: B05BA10
LOT-0016
Lutropin alfa und Follitropin alfa; ATC-Code: G03GA21 (ADV); G03GA30 (WHO)
Lutropin alfa und Follitropin alfa; ATC-Code: G03GA21 (ADV); G03GA30 (WHO)
Location
Duration
Category
Award details
Lutropin alfa und Follitropin alfa
ATC-Code: G03GA21 (ADV)
G03GA30 (WHO)
LOT-0017
Mebendazol; ATC-Code: P02CA01
Mebendazol; ATC-Code: P02CA01
Location
Duration
Category
Award details
Mebendazol
ATC-Code: P02CA01
LOT-0018
Mebeverin; Retardkapseln; ATC-Code: A03AA04
Mebeverin; Retardkapseln; ATC-Code: A03AA04
Location
Duration
Category
Award details
Mebeverin
Retardkapseln
ATC-Code: A03AA04
LOT-0019
Menotropin; ATC-Code: G03GA02
Menotropin; ATC-Code: G03GA02
Location
Duration
Category
Award details
Menotropin
ATC-Code: G03GA02
LOT-0020
Methylprednisolon; Tabletten; ATC-Code: H02AB04
Methylprednisolon; Tabletten; ATC-Code: H02AB04
Location
Duration
Category
Award details
Methylprednisolon
Tabletten
ATC-Code: H02AB04
LOT-0021
Natriumphenylbutyrat; ATC-Code: A16AX03
Natriumphenylbutyrat; ATC-Code: A16AX03
Location
Duration
Category
Award details
Natriumphenylbutyrat
ATC-Code: A16AX03
LOT-0022
Nystatin und Zinkoxid; ATC-Code: D01AA91 (ADV); D01AA (WHO)
Nystatin und Zinkoxid; ATC-Code: D01AA91 (ADV); D01AA (WHO)
Location
Duration
Category
Award details
Nystatin und Zinkoxid
ATC-Code: D01AA91 (ADV)
D01AA (WHO)
LOT-0023
Olaparib; ATC-Code: L01XK01
Olaparib; ATC-Code: L01XK01
Location
Duration
Category
Award details
Olaparib
ATC-Code: L01XK01
LOT-0024
Perindopril arginin und Indapamid; Filmtabletten, Tabletten; Packungsgröße: 90 FTA oder TAB; ATC-Code: C09BA54 (ADV); C09BA04 (WHO)
Perindopril arginin und Indapamid; Filmtabletten, Tabletten; Packungsgröße: 90 FTA oder TAB; ATC-Code: C09BA54 (ADV); C09BA04 (WHO)
Location
Duration
Category
Award details
Perindopril arginin und Indapamid
Filmtabletten, Tabletten
Packungsgröße: 90 FTA oder TAB
ATC-Code: C09BA54 (ADV)
C09BA04 (WHO)
LOT-0025
Rilpivirin; Filmtabletten; ATC-Code: J05AG05
Rilpivirin; Filmtabletten; ATC-Code: J05AG05
Location
Duration
Category
Award details
Rilpivirin
Filmtabletten
ATC-Code: J05AG05
LOT-0026
Rotigotin; Pflaster transdermal; Packungsgröße: 8-12 PFT sowie 95-100 PFT; ATC-Code: N04BC09
Rotigotin; Pflaster transdermal; Packungsgröße: 8-12 PFT sowie 95-100 PFT; ATC-Code: N04BC09
Location
Duration
Category
Award details
Rotigotin
Pflaster transdermal
Packungsgröße: 8-12 PFT sowie 95-100 PFT
ATC-Code: N04BC09
LOT-0027
Sultiam; ATC-Code: N03AX03
Sultiam; ATC-Code: N03AX03
Location
Duration
Category
Award details
Sultiam
ATC-Code: N03AX03
LOT-0028
Testosteron; Gel; ATC-Code: G03BA03
Testosteron; Gel; ATC-Code: G03BA03
Location
Duration
Category
Award details
Testosteron
Gel
ATC-Code: G03BA03
LOT-0029
Timolol; Augentropfen in Pipetten; ATC-Code: S01ED01
Timolol; Augentropfen in Pipetten; ATC-Code: S01ED01
Location
Duration
Category
Award details
Timolol
Augentropfen in Pipetten
ATC-Code: S01ED01
LOT-0030
Tinzaparin; ATC-Code: B01AB10
Tinzaparin; ATC-Code: B01AB10
Location
Duration
Category
Award details
Tinzaparin
ATC-Code: B01AB10
LOT-0031
Treprostinil; ATC-Code: B01AC21
Treprostinil; ATC-Code: B01AC21
Location
Duration
Category
Award details
Treprostinil
ATC-Code: B01AC21
LOT-0032
Lanreotid; ATC-Code: H01CB03
Lanreotid; ATC-Code: H01CB03
Location
Duration
Category
Award details
Lanreotid
ATC-Code: H01CB03
Procurement Details
- Publication date
- 28 Jan 2026
- Languages
- German
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 65041-2026
Documents (1)
Similar tenders
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)
Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР
Belgium – Pharmaceutical products – Antimycotica
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)
Denmark – Pharmaceutical products – Amgros 2027 1.1170.a
Opportunity Score
Why this score?
Opportunity
50 / 100
Complexity
40 / 100
Risk factors
No estimated contract value or volume provided; cannot assess potential revenue
Procedure described as open-house but uses standard tender form; legal implications unclear
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications